| Insulin receptor isoforms in physiology and disease: an updated view A Belfiore, R Malaguarnera, V Vella, MC Lawrence, L Sciacca, F Frasca, ... Endocrine reviews 38 (5), 379-431, 2017 | 373 | 2017 |
| A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer V Vella, G Pandini, L Sciacca, R Mineo, R Vigneri, V Pezzino, A Belfiore The Journal of Clinical Endocrinology & Metabolism 87 (1), 245-254, 2002 | 294 | 2002 |
| BRAF (V600E) mutation and the biology of papillary thyroid cancer F Frasca, C Nucera, G Pellegriti, P Gangemi, M Attard, M Stella, M Loda, ... Endocrine-related cancer 15 (1), 191, 2008 | 293 | 2008 |
| The IGF system in thyroid cancer: new concepts V Vella, L Sciacca, G Pandini, R Mineo, S Squatrito, R Vigneri, A Belfiore Molecular Pathology 54 (3), 121, 2001 | 250 | 2001 |
| Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid R Malaguarnera, F Frasca, A Garozzo, F Gianì, G Pandini, V Vella, ... The Journal of Clinical Endocrinology & Metabolism 96 (3), 766-774, 2011 | 171 | 2011 |
| Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer A Belfiore, G Pandini, V Vella, S Squatrito, R Vigneri Biochimie 81 (4), 403-407, 1999 | 143 | 1999 |
| p53 family proteins in thyroid cancer R Malaguarnera, V Vella, R Vigneri, F Frasca Endocrine-Related Cancer 14 (1), 43-60, 2007 | 110 | 2007 |
| Insulin receptor isoforms in cancer V Vella, A Milluzzo, NM Scalisi, P Vigneri, L Sciacca International journal of molecular sciences 19 (11), 3615, 2018 | 101 | 2018 |
| PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis V Vella, ML Nicolosi, S Giuliano, M Bellomo, A Belfiore, R Malaguarnera Frontiers in endocrinology 8, 244472, 2017 | 89 | 2017 |
| Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor F Frasca, P Vigneri, V Vella, R Vigneri, JYJ Wang Oncogene 20 (29), 3845-3856, 2001 | 84 | 2001 |
| IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway R Matà, C Palladino, ML Nicolosi, ARL Presti, R Malaguarnera, M Ragusa, ... Oncotarget 7 (7), 7683, 2016 | 81 | 2016 |
| p73 tumor-suppressor activity is impaired in human thyroid cancer F Frasca, V Vella, A Aloisi, A Mandarino, E Mazzon, R Vigneri, P Vigneri Cancer Research 63 (18), 5829-5837, 2003 | 75 | 2003 |
| Insulin resistance: any role in the changing epidemiology of thyroid cancer? R Malaguarnera, V Vella, ML Nicolosi, A Belfiore Frontiers in endocrinology 8, 308430, 2017 | 69 | 2017 |
| Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells RL Messina, M Sanfilippo, V Vella, G Pandini, P Vigneri, ML Nicolosi, ... International journal of cancer 130 (10), 2259-2270, 2012 | 66 | 2012 |
| Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells RL Messina, M Sanfilippo, V Vella, G Pandini, P Vigneri, ML Nicolosi, ... International journal of cancer 130 (10), 2259-2270, 2012 | 66 | 2012 |
| Levels of histone acetylation in thyroid tumors C Puppin, N Passon, E Lavarone, C Di Loreto, F Frasca, V Vella, ... Biochemical and Biophysical Research Communications 411 (4), 679-683, 2011 | 63 | 2011 |
| Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses R Malaguarnera, ML Nicolosi, A Sacco, A Morcavallo, V Vella, C Voci, ... Oncotarget 6 (18), 16084, 2015 | 62 | 2015 |
| The p53-homologue p63 may promote thyroid cancer progression R Malaguarnera, A Mandarino, E Mazzon, V Vella, P Gangemi, ... Endocrine-Related Cancer 12 (4), 953-971, 2005 | 62 | 2005 |
| Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves’ disease V Vella, R Mineo, F Frasca, E Mazzon, G Pandini, R Vigneri, A Belfiore The Journal of Clinical Endocrinology & Metabolism 89 (6), 2880-2889, 2004 | 57 | 2004 |
| Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer V Vella, R Malaguarnera, R Lappano, M Maggiolini, A Belfiore Molecular and Cellular Endocrinology 457, 57-72, 2017 | 56 | 2017 |
Antonino BelfioreProfessor of Endocrinology, University of CataniaVerified email at unict.it
